Table T2_3_1_1-1_2a

2012 National Healthcare Quality and Disparities Reports

This appendix provides detailed data tables for all measures analyzed for the 2012 National Healthcare Quality and Disparities Reports. Tables are included for measures discussed in the main text of the reports as well as for other measures that were examined but not included in the main text.

Table 2_3_1_1.1_2a
End stage renal disease patients age 18 and over who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy,^a by race, United States, 2009
		Total		White		Black		Asian		AI/AN
Population group		Percent	SE	Percent	SE	Percent	SE	Percent	SE	Percent	SE
Total		28.3	0.1	29.8	0.2	24.8	0.3	27.7	0.7	DNA	DNA
Age	18–44	23.4	0.4	26.4	0.5	18.9	0.6	26.2	1.7	DNA	DNA
	45–64	27.2	0.2	28.7	0.3	24.6	0.4	27.3	1.1	DNA	DNA
	65 and over	30.4	0.2	31.2	0.3	28.1	0.5	28.4	1.0	DNA	DNA
Gender	Male	28.0	0.2	29.7	0.2	23.7	0.4	27.1	0.9	DNA	DNA
Gender	Female	28.6	0.2	29.9	0.3	26.1	0.4	28.3	1.0	DNA	DNA

^a Denominator includes all incident end stage renal disease patients age 18 and over with valid CMS-2728 Medical Evidence form, and a nonmissing value for the question: Did you see a nephrologist at all? Numerator includes those who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy.

DNA - Data have not been analyzed.

Key: AI/AN: American Indian/Alaska Native; SE: standard error.

Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, United States Renal Data System.

Page last reviewed June 2013

Internet Citation: Table T2_3_1_1-1_2a: 2012 National Healthcare Quality and Disparities Reports. June 2013. Agency for Healthcare Research and Quality, Rockville, MD. http://archive.ahrq.gov/research/findings/nhqrdr/nhqrdr12/3_chronickidneydisease/T2_3_1_1-1_2a.html